TechForce Robotics, a subsidiary of Nightfood Holdings, has successfully deployed its autonomous laboratory support robot LIM-E at Oncotelic Therapeutics, completing Phase 1 of their joint development agreement. This deployment marks TechForce's first move into pharmaceutical and laboratory automation, expanding its AI-driven robotics platform beyond hospitality into high-value life sciences and pharmaceutical sectors. The collaboration aims to improve efficiency and scalability in pharmaceutical manufacturing and lab workflows, with future phases exploring additional automation opportunities. This initiative supports Nightfood's broader strategy to grow its Robotics-as-a-Service platform across multiple industries including healthcare and biotech.
Vantage Bancorp Inc. reported Q2 2026 earnings per share of $0.29, surpassing analyst estimates of $0.28 and up from $0.18 a year ago. The company posted revenue of $28.2 million, exceeding expectations of $26.9 million, driven by 27% year-over-year ...
Valneva announced an update on its share capital and voting rights as of May 31, 2026. The company reported a total of 189,771,237 ordinary shares with a nominal value of €0.15 each, and a total of 204,363,287 voting rights including suspended rights...
Valneva declared its shares and voting rights status as of May 31, 2026, reporting 189,771,237 ordinary shares and a total of 204,238,965 exercisable voting rights after accounting for double voting rights on some shares. This update is important for...
Integrated Quantum Technologies introduced VEIL™, a privacy-focused tool integrated into Snowflake's AI Data Cloud, which removes personally identifiable information (PII) from data before it is used in AI and machine learning models. This approach a...
Bluejay Diagnostics announced a private placement to raise up to $23.6 million, including $8.5 million upfront, to extend its cash runway into early 2027. The funds will support FDA submission and commercialization of its rapid sepsis testing system,...
